Utolsó frissítés :
19/11/2024
Immunszuppresszív szer   Tacrolimus  
Injekció
belsőleges oldat Szemcsepp
Az oldatok stabilitása A keverékek stabilitása Stabilitást befolyásoló tényezők Kompatibilitás Az alkalmazás módja Irodalom pdf
   Kémiai szerkezet   

Kereskedelmi név   Kereskedelmi név     

A kereskedelmi név meghatározó jelentőségű: a készítmények összetétele országonként, előállítóként eltérő lehet

Prograf Amerikai Egyesült Államok, Ausztrália, Ausztria, Chile, Colombia, Dánia, Finnország, Franciaország, Görögország, Irán, Írország, Japán, Kanada, Lengyelország, Magyarország, Malaysia, Nagy-Britannia, Németország, Norvégia, Olaszország, Portugália, Románia, Spanyolország, Svájc, Svédország, új-Zéland
Prograft Belgium, Hollandia, Luxemburg
Irodalom   Injekció   Irodalom : Tacrolimus  
Type publikáció
207 Napló Ku YM, Min DI, Kumar V, Noormohamed SE.
Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection.
Am J Health-Syst Pharm 1995 ; 52: 2024-2025.
301 Napló Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM.
Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1295-1300.
475 Napló Taormina D, Abdallah HY, Venkataramanan R, Logue L, Burckart GJ, Ptachcinski RJ, Todo S, Fung JJ, Starzl TE.
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers.
Am J Hosp Pharm 1992 ; 49: 119-122.
479 Napló Min DI, Brown T, HWang GC.
Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 2964-2966.
814 Napló Johnson CE, VandenBussche HL, Chio CC, Jacobson PA.
Stability of tacrolimus with morphine sulfate, hydromorphone hydrochloride, and ceftazidime during simulated intravenous coadministration.
Am J Health-Syst Pharm 1999 ; 56: 164-169.
907 Napló Ku YM, Min DI, Kumar V, Noormohamed SA.
Stability of tacrolimus injection in total parenteral nutrition solution.
J Pharm Technol 1996 ; 12: 58-61.
1415 Napló Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M.
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
JPEN 1999 ; 23: 67-74.
1421 Napló Johnson CE, Truong NM.
Stability and compatibility of tacrolimus and fluconazole in 0.9% sodium chloride.
J Am Pharm Assoc 1999 ; 39: 505-509.
1982 Napló Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2108 Napló Trusley C, Kupiec TC, Trissel LA.
Compatibility of micafungin injection with other drugs during simulated Y-site co-administration.
Int J Pharm Compound 2006 ; 10: 230-232.
2192 Napló Cochran BG, Sowinski KM, Fausel C, Overholser BR.
Physical compatibility and chemical stability of mycophenolate mofetil during simulated Y-site administration with commonly coadministered drugs.
Am J Health-Syst Pharm 2007 ; 64, 13: 1410-1414.
2247 Napló Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
2262 Napló Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3626 Laboratórium Tacrolimus (Prograf®) - Résumé des Caractéristiques du Produit
Astellas Pharma 2014
3827 poszter Ghazi I.M, Hamada Y, Nicolau D.P.
Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions.
ASHP Midyear 2015
3828 poszter Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829 poszter So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
3842 Napló Lee J.H, Goldspiel B.R, Ryu S, Potti G.K.
Stability of tacrolimus solutions in polyolefin containers.
Am J Health-Syst Pharm 2016 ; 73:137-142.
3915 Napló Myers A.L, Zhang Y, . Kawedia J.D, Shank B.R, Deaver M.A, Kramer M.A.
Stability of tacrolimus injection diluted in 0.9% sodium chloride injection and stored in Excel bags
Am J Health-Syst Pharm 2016 ; 73,24: 2083-2088.
3948 Napló Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P .
Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation.
JPEN 2012 ;30. 416?424.
4521 Napló Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B.
Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit.
Pharmaceutical Technology in Hospital Pharmacy 2020

  Mentions Légales